Komori
Renascience (4889) · InitiativeFirst stated

Deficit offset and strengthening of the financial position through a reduction in capital reserves

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Capital Policy and Dividend Preparation Through Capital Reduction and Deficit CompensationA theme 312 companies write about · 1 as a headwind · 311 as a tailwind

13 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 314 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1First statedAnnual report

    「As of 7 August 2026, pursuant to the provisions of Article 448, Paragraph 1 of the Companies Act, the company reduced its capital reserve by ¥1,136,328 thousand and transferred the entire amount to other capital surplus.」

    As of 7 August 2026, the company reduced its capital reserve by ¥1,136,328 thousand and applied the amount, via other capital surplus, to offset the deficit in retained earnings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Renascience yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Deficit offset and strengthening of the financial position through a reduction in capital reserves | Renascience Inc. (4889) | Komori